STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
19.20
+0.22 (1.16%)
At close: Jul 25, 2025, 4:00 PM
19.20
0.00 (0.00%)
After-hours: Jul 25, 2025, 4:00 PM EDT
STAAR Surgical Company Stock Forecast
Stock Price Forecast
The 7 analysts that cover STAAR Surgical Company stock have a consensus rating of "Hold" and an average price target of $18.2, which forecasts a -5.21% decrease in the stock price over the next year. The lowest target is $16 and the highest is $20.
Price Target: $18.2 (-5.21%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for STAAR Surgical Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | -6.25% | Jul 16, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $20 | Hold | Maintains | $20 | +4.17% | May 27, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 21, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $17 → $20 | Hold | Maintains | $17 → $20 | +4.17% | May 8, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $17 | Hold | Reiterates | $17 | -11.46% | Mar 18, 2025 |
Financial Forecast
Revenue This Year
260.54M
from 313.90M
Decreased by -17.00%
Revenue Next Year
333.05M
from 260.54M
Increased by 27.83%
EPS This Year
-1.76
from -0.41
EPS Next Year
-0.15
from -1.76
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 286.4M | 411.2M | 441.6M | ||
| Avg | 260.5M | 333.1M | 360.7M | ||
| Low | 237.7M | 275.2M | 299.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -8.7% | 57.8% | 32.6% | ||
| Avg | -17.0% | 27.8% | 8.3% | ||
| Low | -24.3% | 5.6% | -10.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.29 | 0.51 | 1.54 | ||
| Avg | -1.76 | -0.15 | 0.37 | ||
| Low | -2.08 | -0.66 | -0.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.